On Demand | Academy of Breast Oncology | Recent Advances in the Biology of Breast Cancer

Τα πιστοποιητικά είναι διαθέσιμα!
Δεν υπάρχουν διαθέσιμα δεδομένα. Επικοινωνήστε μαζί μας μέσω email ζητώντας την πιστοποίησή σας ή καλέστε μας για να σας βοηθήσουμε.
  • 18.00-18.30 CET
    From Keynote 522 regimen for all to precision immune-oncology

    Michail Ignatiadis (BE)

  • 18.30-19.00 CET
    New targets for the ER

    Komal Jhaveri (US)

  • 19.00-19.30 CET
    Using artificial intelligence for drug discovery

    Frederick Howard (US)

  • 19.30-20.00 CET
    ADCs: What is new

    Aditya Bardia (US)

  • 20.00-20.15 CET
Aditya Bardia
MD, MPH, FASCO, Professor of Medicine (p), Geffen School of Medicine at UCLA, Director, Breast Oncology Program; Assistant Chief (Translational Research), Division of Medical Oncology, Director of Translational Research Integration, UCLA Health Jonsson Comprehensive Cancer Center, USA
Frederick Howard
Assistant Professor of Medicine, University of Chicago Medicine, USA
Komal Jhaveri
MD, FACP, Patricia James Cayne Chair for Junior Faculty, Associate Attending, Breast Medicine Service and Early Drug Development Service, Section Head, Endocrine Therapy Research Program, Clinical Director, Early Drug Development Service, Department of Medicine, Memorial Sloan Kettering Cancer Center / Evelyn H. Lauder Breast And Imaging Center, NY / Associate Professor, Weil Cornell, Medical College NY, NY, USA
Michail Ignatiadis
MD, PhD, Director, Breast Medical Oncology Clinic & Program, Medical Oncology Department, Institut Bordet, Université Libre de Bruxelles / Chair, Breast Cancer Group, EORTC
Virginia Kaklamanis
MD DSc, Professor of Medicine, Ruth McLean Bowman Bowers Chair in Breast Cancer Research and Treatment, A.B. Alexander Distinguished Chair in Oncology, Leader, Breast Oncology Program, UT Health San Antonio, MD Anderson Cancer Center, USA
Event Details